Neural network methods for identification and optimization of quantum mechanical features needed for bioactivity

Benjamin B. Braunheim, Steven D Schwartz

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

This paper presents a new approach to the discovery and design of bioactive compounds. The focus of this application will be on the analysis of enzymatic inhibitors. At present the discovery of enzymatic inhibitors for therapeutic use is often accomplished through random searches. The first phase of discovery is a random search through a large pre-fabricated chemical library. Many molecules are tested with refined enzyme for signs of inhibition. Once a group of lead compounds have been discovered the chemical intuition of biochemists is used to find structurally related compounds that are more effective. This step requires new molecules to be conceived and synthesized, and it is the most time-consuming and expensive step. The development of computational and theoretical methods for prediction of the molecular structure that would bind most tightly prior to synthesis and testing, would facilitate the design of novel inhibitors. In the past, our work has focused on solving the problem of predicting the bioactivity of a molecule prior to synthesis. We used a neural network trained with the bioactivity of known compounds to predict the bioactivity of unknown compounds. In our current work, we use a separate neural network in conjunction with a trained neural network in an attempt to gain insight as to how to modify existing compounds and increase their bioactivity. (C) 2000 Academic Press.

Original languageEnglish (US)
Pages (from-to)27-45
Number of pages19
JournalJournal of Theoretical Biology
Volume206
Issue number1
DOIs
StatePublished - Sep 7 2000
Externally publishedYes

Fingerprint

Small Molecule Libraries
Intuition
Therapeutic Uses
Bioactivity
Molecular Structure
neural networks
Inhibitor
Random Search
Molecules
Neural Networks
Neural networks
Optimization
Enzymes
Synthesis
synthesis
Lead compounds
Enzyme inhibition
chemical structure
methodology
Molecular structure

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)

Cite this

Neural network methods for identification and optimization of quantum mechanical features needed for bioactivity. / Braunheim, Benjamin B.; Schwartz, Steven D.

In: Journal of Theoretical Biology, Vol. 206, No. 1, 07.09.2000, p. 27-45.

Research output: Contribution to journalArticle

@article{16d0ba81e1864935b517a4da84680852,
title = "Neural network methods for identification and optimization of quantum mechanical features needed for bioactivity",
abstract = "This paper presents a new approach to the discovery and design of bioactive compounds. The focus of this application will be on the analysis of enzymatic inhibitors. At present the discovery of enzymatic inhibitors for therapeutic use is often accomplished through random searches. The first phase of discovery is a random search through a large pre-fabricated chemical library. Many molecules are tested with refined enzyme for signs of inhibition. Once a group of lead compounds have been discovered the chemical intuition of biochemists is used to find structurally related compounds that are more effective. This step requires new molecules to be conceived and synthesized, and it is the most time-consuming and expensive step. The development of computational and theoretical methods for prediction of the molecular structure that would bind most tightly prior to synthesis and testing, would facilitate the design of novel inhibitors. In the past, our work has focused on solving the problem of predicting the bioactivity of a molecule prior to synthesis. We used a neural network trained with the bioactivity of known compounds to predict the bioactivity of unknown compounds. In our current work, we use a separate neural network in conjunction with a trained neural network in an attempt to gain insight as to how to modify existing compounds and increase their bioactivity. (C) 2000 Academic Press.",
author = "Braunheim, {Benjamin B.} and Schwartz, {Steven D}",
year = "2000",
month = "9",
day = "7",
doi = "10.1006/jtbi.2000.2098",
language = "English (US)",
volume = "206",
pages = "27--45",
journal = "Journal of Theoretical Biology",
issn = "0022-5193",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Neural network methods for identification and optimization of quantum mechanical features needed for bioactivity

AU - Braunheim, Benjamin B.

AU - Schwartz, Steven D

PY - 2000/9/7

Y1 - 2000/9/7

N2 - This paper presents a new approach to the discovery and design of bioactive compounds. The focus of this application will be on the analysis of enzymatic inhibitors. At present the discovery of enzymatic inhibitors for therapeutic use is often accomplished through random searches. The first phase of discovery is a random search through a large pre-fabricated chemical library. Many molecules are tested with refined enzyme for signs of inhibition. Once a group of lead compounds have been discovered the chemical intuition of biochemists is used to find structurally related compounds that are more effective. This step requires new molecules to be conceived and synthesized, and it is the most time-consuming and expensive step. The development of computational and theoretical methods for prediction of the molecular structure that would bind most tightly prior to synthesis and testing, would facilitate the design of novel inhibitors. In the past, our work has focused on solving the problem of predicting the bioactivity of a molecule prior to synthesis. We used a neural network trained with the bioactivity of known compounds to predict the bioactivity of unknown compounds. In our current work, we use a separate neural network in conjunction with a trained neural network in an attempt to gain insight as to how to modify existing compounds and increase their bioactivity. (C) 2000 Academic Press.

AB - This paper presents a new approach to the discovery and design of bioactive compounds. The focus of this application will be on the analysis of enzymatic inhibitors. At present the discovery of enzymatic inhibitors for therapeutic use is often accomplished through random searches. The first phase of discovery is a random search through a large pre-fabricated chemical library. Many molecules are tested with refined enzyme for signs of inhibition. Once a group of lead compounds have been discovered the chemical intuition of biochemists is used to find structurally related compounds that are more effective. This step requires new molecules to be conceived and synthesized, and it is the most time-consuming and expensive step. The development of computational and theoretical methods for prediction of the molecular structure that would bind most tightly prior to synthesis and testing, would facilitate the design of novel inhibitors. In the past, our work has focused on solving the problem of predicting the bioactivity of a molecule prior to synthesis. We used a neural network trained with the bioactivity of known compounds to predict the bioactivity of unknown compounds. In our current work, we use a separate neural network in conjunction with a trained neural network in an attempt to gain insight as to how to modify existing compounds and increase their bioactivity. (C) 2000 Academic Press.

UR - http://www.scopus.com/inward/record.url?scp=0034618579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034618579&partnerID=8YFLogxK

U2 - 10.1006/jtbi.2000.2098

DO - 10.1006/jtbi.2000.2098

M3 - Article

VL - 206

SP - 27

EP - 45

JO - Journal of Theoretical Biology

JF - Journal of Theoretical Biology

SN - 0022-5193

IS - 1

ER -